CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-05-29
DOI
10.3389/fimmu.2020.00976
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytokines and Chemokines in the Pathogenesis of Experimental Autoimmune Encephalomyelitis
- (2020) William J. Karpus JOURNAL OF IMMUNOLOGY
- Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy
- (2019) Melvyn T. Chow et al. IMMUNITY
- Inflammatory Activation of Astrocytes Facilitates Melanoma Brain Tropism via the CXCL10-CXCR3 Signaling Axis
- (2019) Hila Doron et al. Cell Reports
- Targeting of CXCR3 improves anti-myeloma efficacy of adoptively transferred activated natural killer cells
- (2019) Valentina Bonanni et al. Journal for ImmunoTherapy of Cancer
- Chemokines and cancer: new immune checkpoints for cancer therapy
- (2018) Nathan Karin CURRENT OPINION IN IMMUNOLOGY
- Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity
- (2018) Nathan Karin et al. CYTOKINE
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Digital PCR-Based T-cell Quantification–Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal Melanoma
- (2018) Mark J. de Lange et al. MOLECULAR CANCER RESEARCH
- Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers
- (2018) Nicolas Jacquelot et al. Frontiers in Immunology
- CCR8+FOXp3+Tregcells as master drivers of immune regulation
- (2017) Yiftah Barsheshet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CCR5 Directs the Mobilization of CD11b + Gr1 + Ly6C low Polymorphonuclear Myeloid Cells from the Bone Marrow to the Blood to Support Tumor Development
- (2017) Elias Hawila et al. Cell Reports
- A novel prognostic model for osteosarcoma using circulating CXCL10 and FLT3LG
- (2016) Ricardo J. Flores et al. CANCER
- Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients
- (2016) Niels Halama et al. CANCER CELL
- Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer
- (2016) George Plitas et al. IMMUNITY
- CXCL10/CXCR3 signaling mobilized-regulatory T cells promote liver tumor recurrence after transplantation
- (2016) Chang Xian Li et al. JOURNAL OF HEPATOLOGY
- CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells
- (2016) Chen-Yen Chung et al. Journal of Neuroinflammation
- Monokine induced by interferon gamma (MIG/CXCL9) is an independent prognostic factor in newly diagnosed myeloma
- (2016) Arnold Bolomsky et al. LEUKEMIA & LYMPHOMA
- Biased signaling pathways via CXCR3 control the development and function of CD4+ T cell subsets
- (2015) Nathan Karin et al. JOURNAL OF LEUKOCYTE BIOLOGY
- CXCR3+ Regulatory T Cells Control TH1 Responses in Crescentic GN
- (2015) H.-J. Paust et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
- (2015) Dongjun Peng et al. NATURE
- Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy
- (2015) Rosa Barreira da Silva et al. NATURE IMMUNOLOGY
- Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints
- (2015) M. E. Mikucki et al. Nature Communications
- Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration
- (2015) Timothy J. Zumwalt et al. Oncotarget
- Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells
- (2015) Peter S. Fenwick et al. PLoS One
- IP-10/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival
- (2015) Serena Lunardi et al. Oncotarget
- CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo
- (2014) Erik Wennerberg et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis
- (2014) Yaniv Zohar et al. JOURNAL OF CLINICAL INVESTIGATION
- Heparanase enhances myeloma progression via CXCL10 downregulation
- (2014) U Barash et al. LEUKEMIA
- CXCL10 mRNA expression predicts response to neoadjuvant chemoradiotherapy in rectal cancer patients
- (2014) Cong Li et al. TUMOR BIOLOGY
- Therapeutic effect of anti-C-X-C motif chemokine 10 (CXCL10) antibody on C protein-induced myositis mouse
- (2014) Jinhyun Kim et al. ARTHRITIS RESEARCH & THERAPY
- Evidence for the antagonistic form of CXC-motif chemokine CXCL10 in serous epithelial ovarian tumours
- (2013) Adam Rainczuk et al. INTERNATIONAL JOURNAL OF CANCER
- The CCL5/CCR5 axis promotes metastasis in basal breast cancer
- (2013) Marco Velasco-Velázquez et al. OncoImmunology
- CXCR3+ T Regulatory Cells Selectively Accumulate in Human Ovarian Carcinomas to Limit Type I Immunity
- (2012) N. Redjimi et al. CANCER RESEARCH
- CCR5 Antagonist Blocks Metastasis of Basal Breast Cancer Cells
- (2012) M. Velasco-Velazquez et al. CANCER RESEARCH
- Tumoral Lymphocytic Infiltration and Expression of the Chemokine CXCL10 in Breast Cancers from the Ontario Familial Breast Cancer Registry
- (2012) A. M. Mulligan et al. CLINICAL CANCER RESEARCH
- Dissecting the Autocrine and Paracrine Roles of the CCR2-CCL2 Axis in Tumor Survival and Angiogenesis
- (2012) Liat Izhak et al. PLoS One
- Biased Signaling Pathways in 2-Adrenergic Receptor Characterized by 19F-NMR
- (2012) J. J. Liu et al. SCIENCE
- Molecular Mechanism of β-Arrestin-Biased Agonism at Seven-Transmembrane Receptors
- (2011) Eric Reiter et al. Annual Review of Pharmacology and Toxicology
- A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis
- (2011) Michael Yellin et al. ARTHRITIS AND RHEUMATISM
- Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes
- (2011) Anna Korniejewska et al. IMMUNOLOGY
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
- (2011) Bin-Zhi Qian et al. NATURE
- CXCL10 reduces melanoma proliferation and invasiveness in vitro and in vivo
- (2010) F. Antonicelli et al. BRITISH JOURNAL OF DERMATOLOGY
- Interferons Induce CXCR3-cognate Chemokine Production by Human Metastatic Melanoma
- (2010) Lynn T. Dengel et al. JOURNAL OF IMMUNOTHERAPY
- Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity - a tale of conflict and conundrum
- (2010) M. Müller et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Effective Immunotherapy against Murine Gliomas Using Type 1 Polarizing Dendritic Cells—Significant Roles of CXCL10
- (2009) Mitsugu Fujita et al. CANCER RESEARCH
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
- (2009) H. Harlin et al. CANCER RESEARCH
- CXCL10 expression and prognostic significance in stage II and III colorectal cancer
- (2009) Zheng Jiang et al. MOLECULAR BIOLOGY REPORTS
- CXCL10-Producing Mucosal CD4+ T Cells, NK Cells, and NKT Cells Are Associated with Chronic Colitis in IL-10−/− Mice, Which Can Be Abrogated by Anti-CXCL10 Antibody Inhibition
- (2008) Udai P. Singh et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started